Sutro Biopharma, Inc. (STRO)

Sutro Biopharma Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Sep 30, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Cash & Equivalents	174.58	69.27	47.25	30.41	206.15	4.96
Short-Term Investments	213.68	306.35	287.11	167.52	161.99	112.9
Cash & Short-Term Investments	388.25	375.62	334.36	197.94	368.14	117.86
Cash Growth	9.32%	12.34%	68.92%	-46.23%	212.34%	-42.36%
Receivables	6.66	36.08	7.12	12.45	5.56	6.3
Prepaid Expenses	10.87	9.85	11.67	8.12	4.49	4.41
Total Current Assets	405.78	421.54	353.15	218.52	378.18	128.57
Property, Plant & Equipment	38.02	44.76	51.06	51.59	12.94	9.63
Long-Term Investments	-	-	-	68.78	-	15.61
Other Long-Term Assets	8.03	4.44	2.73	2.53	2.99	2.56
Total Assets	451.83	470.74	406.94	341.41	394.11	156.37
Accounts Payable	6.22	9.44	4.8	6.01	5.54	5.58
Accrued Expenses	41.83	34.1	24.83	17.07	8.82	6.02
Current Portion of Long-Term Debt	-	4.06	12.5	9.38	-	1
Current Portion of Leases	7.2	6.42	4.59	1.04	-	-
Current Income Taxes Payable	0.02	15.17	-	-	-	-
Current Unearned Revenue	72.56	20.67	16.76	5.5	14.6	19.47
Other Current Liabilities	3.46	3.9	3.08	2.75	0.63	0.9
Total Current Liabilities	131.29	93.75	66.55	41.74	29.6	32.97
Long-Term Debt	-	-	3.77	15.74	24.55	8.88
Long-Term Leases	17.66	23.15	29.57	31.22	-	-
Long-Term Unearned Revenue	189.97	202.49	89.89	-	6.1	16.2
Other Long-Term Liabilities	1.69	1.69	0.12	0.15	1.82	0.54
Total Liabilities	340.61	321.09	189.9	88.84	62.06	58.58
Common Stock	0.08	0.06	0.06	0.05	0.05	0.02
Additional Paid-In Capital	825.46	708.98	670.22	586.24	559.75	293.35
Retained Earnings	-714.43	-559.41	-452.62	-333.41	-227.87	-195.75
Comprehensive Income & Other	0.11	0.02	-0.62	-0.31	0.13	0.17
Total Common Equity	111.22	149.65	217.05	252.56	332.05	97.79
Shareholders' Equity	111.22	149.65	217.05	252.56	332.05	97.79
Total Liabilities & Equity	451.83	470.74	406.94	341.41	394.11	156.37
Total Debt	24.86	33.64	50.43	57.37	24.55	9.88
Net Cash (Debt)	363.39	341.98	283.93	209.34	343.59	123.6
Net Cash Growth	14.64%	20.44%	35.63%	-39.07%	177.99%	-34.87%
Net Cash Per Share	5.09	5.68	5.60	4.54	10.55	5.38
Filing Date Shares Outstanding	82.46	62.44	60.16	46.38	45.89	23.1
Total Common Shares Outstanding	82.4	61.01	57.5	46.33	45.75	23.1
Working Capital	274.49	327.8	286.61	176.78	348.59	95.6
Book Value Per Share	1.35	2.45	3.77	5.45	7.26	4.23
Tangible Book Value	111.22	149.65	217.05	252.56	332.05	97.79
Tangible Book Value Per Share	1.35	2.45	3.77	5.45	7.26	4.23
Machinery	-	40	37.63	31.82	32.79	27.59
Construction In Progress	-	0.5	1.69	0.51	1.08	-
Leasehold Improvements	-	23.61	23.22	23.65	15.9	15.9

Source: S&P Capital IQ. Standard template. Financial Sources.